◆英語タイトル：Audentes Therapeutics Inc (BOLD) - Financial and Strategic SWOT Analysis Review
Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myopathy; AT982, for the treatment of Pompe disease; AT342, for the treatment of crigler-najjar syndrome; and AT307, for the treatment of CASQ2-related catecholaminergic polymorphic ventricular tachycardia. Audentes offers viral vectors for gene therapy most frequently and track record off adeno-associated virus vector (AAV) in non-pathogenic product, among others. The company has collaboration with various patient, research and medical communities to advance its product candidates. Audentes is headquartered in San Francisco, California, the US.
Audentes Therapeutics Inc Key Recent Developments
Feb 27,2019: Audentes Therapeutics reports fourth quarter 2018 and full year financial results and provides corporate update
Jan 31,2019: Audentes Therapeutics Announces Next Steps in the Development of AT132 to Treat XLMTM Following Collaborative Initial Meeting with FDA Under RMAT Designation
Jan 03,2019: Audentes Therapeutics names Eric B. Mosbrooker as Senior Vice President and Chief Commercial Officer
Nov 06,2018: Audentes Therapeutics reports third quarter 2018 financial results and provides corporate update
Nov 05,2018: Audentes Therapeutics board of directors appoints co-founder and chief executive officer Matthew R. Patterson as chairman
This comprehensive SWOT profile of Audentes Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Audentes Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Audentes Therapeutics Inc – Key Information
Audentes Therapeutics Inc – Overview
Audentes Therapeutics Inc – Key Employees
Audentes Therapeutics Inc – Key Employee Biographies
Audentes Therapeutics Inc – Key Operational Heads
Audentes Therapeutics Inc – Major Products and Services
Audentes Therapeutics Inc – History
Audentes Therapeutics Inc – Company Statement
Audentes Therapeutics Inc – Locations And Subsidiaries
Audentes Therapeutics Inc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Audentes Therapeutics Inc – Business Description
Audentes Therapeutics Inc – Corporate Strategy
Audentes Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Audentes Therapeutics Inc – Strengths
Audentes Therapeutics Inc – Weaknesses
Audentes Therapeutics Inc – Opportunities
Audentes Therapeutics Inc – Threats
Audentes Therapeutics Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Audentes Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Audentes Therapeutics Inc, Key Information
Audentes Therapeutics Inc, Key Ratios
Audentes Therapeutics Inc, Share Data
Audentes Therapeutics Inc, Major Products and Services
Audentes Therapeutics Inc, History
Audentes Therapeutics Inc, Key Employees
Audentes Therapeutics Inc, Key Employee Biographies
Audentes Therapeutics Inc, Key Operational Heads
Audentes Therapeutics Inc, Other Locations
Audentes Therapeutics Inc, Subsidiaries
Audentes Therapeutics Inc, Key Manufacturing facilities
Audentes Therapeutics Inc, Key Competitors
Audentes Therapeutics Inc, SWOT Analysis
Audentes Therapeutics Inc, Ratios based on current share price
Audentes Therapeutics Inc, Annual Ratios
Audentes Therapeutics Inc, Interim Ratios
Capital Market Ratios
List of Figures
Audentes Therapeutics Inc, Performance Chart
Audentes Therapeutics Inc, Ratio Charts
| ★海外企業調査レポート[Audentes Therapeutics Inc (BOLD)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら